{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T03:54:34Z","timestamp":1793073274212,"version":"4.5.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2011,1,1]],"date-time":"2011-01-01T00:00:00Z","timestamp":1293840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2011,1]]},"DOI":"10.1016\/j.ymgme.2010.09.003","type":"journal-article","created":{"date-parts":[[2010,9,18]],"date-time":"2010-09-18T08:51:43Z","timestamp":1284799903000},"page":"49-56","source":"Crossref","is-referenced-by-count":105,"title":["Efficient analysis of urinary glycosaminoglycans by LC-MS\/MS in mucopolysaccharidoses type I, II and VI"],"prefix":"10.1016","volume":"102","author":[{"given":"Christiane","family":"Auray-Blais","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Bh\u00e9rer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ren\u00e9","family":"Gagnon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah P.","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoyue H.","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joe T.R.","family":"Clarke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David S.","family":"Millington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymgme.2010.09.003_bb0005","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1002\/ajmg.a.32812","article-title":"Mucopolysaccharidosis type I in 21 Czech and Slovak patients: mutation analysis suggests a functional importance of C-terminus of the IDUA protein","volume":"149A","author":"Vazna","year":"2009","journal-title":"Am. J. Med. Genet. A"},{"key":"10.1016\/j.ymgme.2010.09.003_bb0010","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1002\/ajmg.a.32781","article-title":"Incidence of the mucopolysaccharidoses in Taiwan, 1984\u20132004","volume":"149A","author":"Lin","year":"2009","journal-title":"Am. J. Med. Genet. A"},{"key":"10.1016\/j.ymgme.2010.09.003_bb0015","doi-asserted-by":"crossref","first-page":"E29","DOI":"10.1136\/jmg.37.10.e29","article-title":"MPS II in females: molecular basis of two different cases","volume":"37","author":"Cudry","year":"2000","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.ymgme.2010.09.003_bb0020","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.pediatrneurol.2004.10.009","article-title":"Mucopolysaccharidosis type II in females: case report and review of literature","volume":"32","author":"Tuschl","year":"2005","journal-title":"Pediatr. Neurol."},{"key":"10.1016\/j.ymgme.2010.09.003_bb0025","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1007\/s10545-009-1119-7","article-title":"Mortality and cause of death in mucopolysaccharidosis type II-a historical review based on data from the Hunter Outcome Survey (HOS)","volume":"32","author":"Jones","year":"2009","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2010.09.003_bb0030","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1016\/j.jpeds.2004.01.052","article-title":"The mucopolysaccharidoses: a heterogeneous group of disorders with variable pediatric presentations","volume":"144","author":"Muenzer","year":"2004","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ymgme.2010.09.003_bb0035","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s10545-005-5263-4","article-title":"Measurement of urinary CDH and CTH by tandem mass spectrometry in patients hemizygous and heterozygous for Fabry disease","volume":"28","author":"Mills","year":"2005","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2010.09.003_bb0040","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S1096-7192(03)00018-0","article-title":"Determination of monosaccharides and disaccharides in mucopolysaccharidoses patients by electrospray ionisation mass spectrometry","volume":"78","author":"Ramsay","year":"2003","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2010.09.003_bb0045","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1542\/peds.2004-0583","article-title":"Newborn screening for lysosomal storage disorders: clinical evaluation of a two-tier strategy","volume":"114","author":"Meikle","year":"2004","journal-title":"Pediatrics"},{"key":"10.1016\/j.ymgme.2010.09.003_bb0050","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.ymgme.2004.07.015","article-title":"Determination of oligosaccharides and glycolipids in amniotic fluid by electrospray ionisation tandem mass spectrometry: in utero indicators of lysosomal storage diseases","volume":"83","author":"Ramsay","year":"2004","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2010.09.003_bb0055","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1002\/mas.10073","article-title":"Mass spectrometry of oligosaccharides","volume":"23","author":"Zaia","year":"2004","journal-title":"Mass Spectrom. Rev."},{"key":"10.1016\/j.ymgme.2010.09.003_bb0060","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0003-2697(03)00056-3","article-title":"Analysis of a glucose tetrasaccharide elevated in Pompe disease by stable isotope dilution-electrospray ionization tandem mass spectrometry","volume":"316","author":"Young","year":"2003","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.ymgme.2010.09.003_bb0065","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1373\/clinchem.2008.104711","article-title":"Multiplex enzyme assay screening of dried blood spots for lysosomal storage disorders by using tandem mass spectrometry","volume":"54","author":"Zhang","year":"2008","journal-title":"Clin. Chem."},{"key":"10.1016\/j.ymgme.2010.09.003_bb0070","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1373\/clinchem.2004.035907","article-title":"Direct multiplex assay of lysosomal enzymes in dried blood spots for newborn screening","volume":"50","author":"Li","year":"2004","journal-title":"Clin. Chem."},{"key":"10.1016\/j.ymgme.2010.09.003_bb0075","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1373\/clinchem.2008.112110","article-title":"Rapid and effective screening for lysosomal storage disease: how close are we?","volume":"54","author":"Millington","year":"2008","journal-title":"Clin. Chem."},{"key":"10.1016\/j.ymgme.2010.09.003_bb0080","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0065-3101(24)00309-8","article-title":"Mucopolysaccharidoses","volume":"33","author":"Muenzer","year":"1986","journal-title":"Adv. Pediatr."},{"key":"10.1016\/j.ymgme.2010.09.003_bb0085","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0009-9120(87)80088-7","article-title":"Screening for mucopolysaccharide disorders with the Berry spot test","volume":"20","author":"Berry","year":"1987","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.ymgme.2010.09.003_bb0090","unstructured":"V. Shih Toluidine Blue O Spot Test (Berry Spot Test)\" and \"Alcian Blue Spot Test\", Chap. 5, 103-106; 109-118, in: Laboratory Techniques for the Detection of Hereditary Metabolic Disorders, CRC Press, Cleveland, Ohio, 1974."},{"key":"10.1016\/j.ymgme.2010.09.003_bb0095","first-page":"21","article-title":"A colorimetric method for the determination of sulphated glycosaminoglycans.","volume":"11","author":"Humbel","year":"1974","journal-title":"Rev. Roum. Biochim."},{"key":"10.1016\/j.ymgme.2010.09.003_bb0100","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1093\/clinchem\/35.10.2074","article-title":"Diagnostic test for mucopolysaccharidosis. II. Rapid quantification of glycosaminoglycan in urine samples collected on a paper matrix","volume":"35","author":"Whitley","year":"1989","journal-title":"Clin. Chem."},{"key":"10.1016\/j.ymgme.2010.09.003_bb0105","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1093\/clinchem\/35.7.1472","article-title":"Dimethylmethylene blue-based spectrophotometry of glycosaminoglycans in untreated urine: a rapid screening procedure for mucopolysaccharidoses","volume":"35","author":"de Jong","year":"1989","journal-title":"Clin. Chem."},{"key":"10.1016\/j.ymgme.2010.09.003_bb0110","series-title":"The Metabolic and Molecular Basis of Inherited Disease","first-page":"3421","article-title":"The mucopolysaccharidoses","author":"Neufeld","year":"2001"},{"key":"10.1016\/j.ymgme.2010.09.003_bb0115","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1002\/mas.20200","article-title":"On-line separations combined with MS for analysis of glycosaminoglycans","volume":"28","author":"Zaia","year":"2009","journal-title":"Mass Spectrom. Rev."},{"key":"10.1016\/j.ymgme.2010.09.003_bb0120","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.ab.2007.05.016","article-title":"Analytical method for the determination of disaccharides derived from keratan, heparan, and dermatan sulfates in human serum and plasma by high-performance liquid chromatography\/turbo ionspray ionization tandem mass spectrometry","volume":"368","author":"Oguma","year":"2007","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.ymgme.2010.09.003_bb0125","first-page":"207","article-title":"Determination of creatinine by means of automatic chemical analysis","volume":"30","author":"Chasson","year":"1960","journal-title":"Tech. Bull. Regist. Med. Technol."},{"key":"10.1016\/j.ymgme.2010.09.003_bb0130","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.ymgme.2007.10.001","article-title":"Urinary globotriaosylceramide excretion correlates with the genotype in children and adults with Fabry disease","volume":"93","author":"Auray-Blais","year":"2008","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2010.09.003_bb0135","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1007\/s10545-006-0444-3","article-title":"Development of a filter paper method potentially applicable to mass and high-risk urinary screenings for Fabry disease","volume":"30","author":"Auray-Blais","year":"2007","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2010.09.003_bb0140","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1007\/s10545-007-0607-x","article-title":"Quebec neonatal mass urinary screening programme: From micromolecules to macromolecules","volume":"30","author":"Auray-Blais","year":"2007","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2010.09.003_bb0145","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.ymgme.2009.04.006","article-title":"Gb(3)\/creatinine biomarkers for Fabry disease: issues to consider","volume":"97","author":"Auray-Blais","year":"2009","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2010.09.003_bb0150","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s10545-009-1055-6","article-title":"Proposed high-risk screening protocol for Fabry disease in patients with renal and vascular disease","volume":"32","author":"Auray-Blais","year":"2009","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2010.09.003_bb0155","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.ymgme.2009.04.009","article-title":"Fabry disease urinary globotriaosylceramide\/creatinine biomarker evaluation by liquid chromatography-tandem mass spectrometry in healthy infants from birth to 6 months","volume":"97","author":"Barr","year":"2009","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2010.09.003_bb0160","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1093\/glycob\/cwh049","article-title":"Glycosaminoglycan degradation fragments in mucopolysaccharidosis I","volume":"14","author":"Fuller","year":"2004","journal-title":"Glycobiology"},{"key":"10.1016\/j.ymgme.2010.09.003_bb0165","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.ymgme.2009.10.001","article-title":"Validation of disaccharide compositions derived from dermatan sulfate and heparan sulfate in mucopolysaccharidoses and mucolipidoses II and III by tandem mass spectrometry","volume":"99","author":"Tomatsu","year":"2010","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2010.09.003_bb0170","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1203\/01.PDR.0000141987.69757.DD","article-title":"Disease-specific markers for the mucopolysaccharidoses","volume":"56","author":"Fuller","year":"2004","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.ymgme.2010.09.003_bb0175","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1172\/JCI119208","article-title":"Enzyme replacement therapy from birth in a feline model of mucopolysaccharidosis type VI","volume":"99","author":"Crawley","year":"1997","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ymgme.2010.09.003_bb0180","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S1096-7192(03)00007-6","article-title":"Replacement therapy in Mucopolysaccharidosis type VI: advantages of early onset of therapy","volume":"78","author":"Auclair","year":"2003","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2010.09.003_bb0185","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1203\/01.PDR.0000113789.30640.5C","article-title":"Monitoring dose response of enzyme replacement therapy in feline mucopolysaccharidosis type VI by tandem mass spectrometry","volume":"55","author":"Crawley","year":"2004","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.ymgme.2010.09.003_bb0190","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/BF01799385","article-title":"Tandem mass spectrometry: a new method for acylcarnitine profiling with potential for neonatal screening for inborn errors of metabolism","volume":"13","author":"Millington","year":"1990","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2010.09.003_bb0195","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0009-8981(02)00135-3","article-title":"Application of tandem mass spectrometry to biochemical genetics and newborn screening","volume":"322","author":"Carpenter","year":"2002","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.ymgme.2010.09.003_bb0200","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ymgme.2008.10.009","article-title":"A dose-optimization trial of laronidase (Aldurazyme) in patients with mucopolysaccharidosis I","volume":"96","author":"Giugliani","year":"2009","journal-title":"Mol. Genet. Metab."}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719210003446?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719210003446?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,3,30]],"date-time":"2024-03-30T15:47:18Z","timestamp":1711813638000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719210003446"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,1]]}},"alternative-id":["S1096719210003446"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2010.09.003","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2011,1]]}}}